help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Vleet, J. F.
Right arrow Articles by Ferrans, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Vleet, J. F.
Right arrow Articles by Ferrans, V. J.

American Journal of Pathology, Vol 124, 98-178, Copyright © 1986 by American Society for Investigative Pathology


REVIEWS

Myocardial diseases of animals

JF Van Vleet and VJ Ferrans

In this review we have attempted a comprehensive compilation of the cardiac morphologic changes that occur in spontaneous and experimental myocardial diseases of animals. Our coverage addresses diseases of mammals and birds and includes these diseases found in both domesticated and wild animals. A similar review of the myocardial diseases in this broad range of animal species has not been attempted previously. We have summarized and illustrated the gross, microscopic, and ultrastructural alterations for these myocardial diseases; and, whenever possible, we have reviewed their biochemical pathogenesis. We have arranged the myocardial diseases for presentation and discussion according to an etiologic classification with seven categories. These include a group of idiopathic or primary cardiomyopathies recognized in man (hypertrophic, dilated, and restrictive types) and a large group of secondary cardiomyopathies with known causes, such as inherited tendency; nutritional deficiency; toxicity; physical injury and shock; endocrine disorders, and myocarditides of viral, bacterial, and protozoal causation. Considerable overlap exists between each of the etiologic groups in the spectrum of pathologic alterations seen in the myocardium. These include various degenerative changes, myocyte necrosis, and inflammatory lesions. However, some diseases show rather characteristic myocardial alterations such as vacuolar degeneration in anthracycline cardiotoxicity, myofibrillar lysis in furazolidone cardiotoxicity, calcification in calcinosis of mice, glycogen accumulation in the glycogenoses, lipofuscinosis in cattle, fatty degeneration in erucic acid cardiotoxicity, myofiber disarray in hypertrophic cardiomyopathy, and lymphocytic inflammation with inclusion bodies in canine parvoviral myocarditis. The myocardial diseases represent the largest group in the spectrum of spontaneous cardiac diseases of animals. Pericardial and endocardial diseases and congential cardiac diseases are seen less frequently; and, in contrast to man, coronary artery disease and myocardial ischemia are rather infrequent in animals. The present review shows clearly that the spectrum of myocardial diseases in animals is enlarging and that many newly recognized diseases are emerging and assuming considerable importance. For example, various heritable cardiomyopathies have recently been described in the KK mouse, cattle, and rats. Increasingly recognized myocardial diseases include cardiomyopathies in cats, dogs, and birds; anthracycline cardiotoxicity; furazolidone cardiotoxicity; ionophore cardiotoxicity; myocardial damage associated with central nervous system injuries; myocardial hypertrophy in


This article has been cited by other articles:


Home page
Vet PatholHome page
A. Tidholm and L. Jonsson
Histologic Characterization of Canine Dilated Cardiomyopathy
Vet. Pathol., January 1, 2005; 42(1): 1 - 8.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Ponten, X. Li, P. Thoren, K. Aase, T. Sjoblom, A. Ostman, and U. Eriksson
Transgenic Overexpression of Platelet-Derived Growth Factor-C in the Mouse Heart Induces Cardiac Fibrosis, Hypertrophy, and Dilated Cardiomyopathy
Am. J. Pathol., August 1, 2003; 163(2): 673 - 682.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. J. Biesiadecki, B. D. Elder, Z.-B. Yu, and J.-P. Jin
Cardiac Troponin T Variants Produced by Aberrant Splicing of Multiple Exons in Animals with High Instances of Dilated Cardiomyopathy
J. Biol. Chem., December 20, 2002; 277(52): 50275 - 50285.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. R. Fox, S.-K. Liu, and B. J. Maron
Echocardiographic Assessment of Spontaneously Occurring Feline Hypertrophic Cardiomyopathy : An Animal Model of Human Disease
Circulation, November 1, 1995; 92(9): 2645 - 2651.
[Abstract] [Full Text]


Home page
ScienceHome page
P. Pion, M. Kittleson, Q. Rogers, and J. Morris
Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy
Science, August 14, 1987; 237(4816): 764 - 768.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society for Investigative Pathology.